ABLE II ORTHOTICS & PROSTHETICS, INC

ABLE II ORTHOTICS & PROSTHETICS, INC specializes in the design, fabrication, and fitting of custom orthotic and prosthetic devices for individuals requiring mobility and functional restoration support. The company leverages clinical assessment protocols, biomechanical modeling, and advanced materials to deliver patient-specific solutions, including lower-limb prostheses, spinal orthoses, and upper-extremity assistive devices. Their technical expertise includes gait analysis, socket fabrication using thermoplastic and carbon fiber composites, and integration of microprocessor-controlled components for dynamic limb function. Differentiators include a patient-centered rehabilitation approach, adherence to ANSI/ISO orthotic and prosthetic standards, and hands-on clinical collaboration with medical providers to ensure functional outcomes. Award history is not available to confirm specific agency engagements, so no definitive patterns of federal or military client relationships can be inferred. The absence of recent award data precludes identification of primary contracting agencies or programmatic focus areas such as VA Prosthetics, DOD TRICARE, or Public Health Service initiatives. The primary NAICS code 621498, “Other Outpatient Care Centers,” encompasses clinical services related to orthotic and prosthetic care delivery, indicating the company operates within the broader healthcare support services sector. In practice, this reflects a focus on outpatient rehabilitation centers, durable medical equipment provision, and mobility device fitting services, positioning the firm as a specialized provider within the assistive technology submarket. ABLE II ORTHOTICS & PROSTHETICS, INC is structured as a small business (2L) based in Lincoln, Nebraska, with no government certifications disclosed. The company maintains a localized operational footprint, serving regional healthcare networks and clinical partners. Without certified status or federal contract history, its government market presence remains undetermined, though its clinical capabilities align with federal healthcare delivery requirements for prosthetic and orthotic services.